From: Gastroesophageal reflux leads to esophageal cancer in a surgical model with mice
 |  |  | Week 20 | Week 40 | Week 80 | |
---|---|---|---|---|---|---|
Group | Genotype | Treatment | Metaplasia | Metaplasia | Squamous cell carcinoma | Squamous cell carcinoma |
A | Wild-type | Non-operated control | 0/10 | 0/10 | 0/10 | - |
B | Wild-type | Reflux surgery and 50 mg/kg/m Fe, i.p. (Wk 41 to 80) | 1/20 (5%) | 6/37 (16.2%) | 0/37 | 12/13 (92.3%) |
C | p53 A135V | Reflux surgery | 1/19 (5.3%) | 2/42 (4.8%) | 0/42 | - |
D | INK4a/Arf +/- | Reflux surgery | 0/10 | 0/14 | 1/14 (7.1%) | - |
E | Wild-type | Reflux surgery, omeprazole (1,400 ppm) and 50 mg/kg/m Fe, i.p. (Wk 21 to 40) | - | 0/11 | 0/11 | Â |
F | Wild-type | Reflux surgery and 50 mg/kg/m Fe, i.p. (Wk 2 to 40) | - | 0/22 | 0/22 | - |
G | Wild-type | Reflux surgery, gastrectomy and 50 mg/kg/m Fe, i.p. (Wk 2 to 40) | - | 1/14 (6.7%) | 3/14a (21.4%) | - |